Association of Systemic Medication Use with Glaucoma and Intraocular Pressure
Open Access
- 5 May 2023
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 130 (9) , 893-906
Abstract
No abstract availableKeywords
Funding Information
- Fight for Sight
- Johannes Gutenberg University Mainz
- Federal State of Saxony
- Merck and Co Inc
- Erasmus University Rotterdam
- International Glaucoma Association
- Stichting Glaucoomfonds
- Philips
- Texas Technical University Health Sciences Center
- UiT Arctic University of Norway
- UK Research and Innovation
- Horizon 2020 Marie Skłodowska-Curie Actions
- Rhineland Palatinate Foundation for Innovation
- French Government Ministry of Social Affairs Health and Womens Rights
- Cancer Research UK
- Creighton University
- Agence Nationale de la Recherche
- Stichting Blindenhulp
- Nederland Ministerie van Volksgezondheid Welzijn en Sport
- Novartis
- Norwegian Ministry of Health and Care Services
- ZonMw
- European Commission Directorate-General for Research and Innovation
- Stichting Lijf en Leven
- Alcon Research Institute
- Medical Research Council
- Erasmus Medical Center
- University Hospital of North Norway
- Pfizer Inc
- European Regional Development Fund
- Rotterdamse Stichting Blindenbelangen
- Nederland Ministerie van Onderwijs Cultuur en Wetenschap
- Lister Institute of Preventive Medicine
- German Research Foundation
- Boehringer Ingelheim International GmbH
- UCLA
- Landelijke Stichting voor Blinden en Slechtzienden
- Stichting voor Ooglijders
- Oogfonds
This publication has 57 references indexed in Scilit:
- Administration-Time Differences in Effects of Hypertension Medications on Ambulatory Blood Pressure RegulationChronobiology International, 2012
- Cholesterol-Lowering Drugs and Incident Open-Angle Glaucoma: A Population-Based Cohort StudyPLOS ONE, 2012
- Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKDJournal of the American Society of Nephrology, 2011
- Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 DiabetesDiabetes Care, 2011
- Use of calcium channel blockers for glaucomaProgress in Retinal and Eye Research, 2011
- INFLUENCE OF CIRCADIAN TIME OF HYPERTENSION TREATMENT ON CARDIOVASCULAR RISK: RESULTS OF THE MAPEC STUDYChronobiology International, 2010
- Hypotensive Medication, Statins, and the Risk of GlaucomaInvestigative Ophthalmology & Visual Science, 2010
- Systemic Antihypertensive Medication and Incident Open-angle GlaucomaOphthalmology, 2007
- Calcium-Antagonist DrugsNew England Journal of Medicine, 1999
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982